Coeptis Therapeutics Inc.

NASDAQ: COEP · Real-Time Price · USD
13.96
2.48 (21.60%)
At close: Aug 15, 2025, 3:59 PM
13.81
-1.11%
After-hours: Aug 15, 2025, 06:35 PM EDT

Coeptis Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
62.87K 1.86M n/a n/a n/a 1.5M n/a n/a n/a n/a n/a n/a n/a n/a 9.89K n/a 75K
Cost of Revenue
45.16K 931.73K 431.3K 250.21K 250.21K 250.31K 250.31K 250.31K 250.31K 250.35K n/a n/a n/a n/a 1.49K n/a n/a
Gross Profit
17.72K 931.73K -431.3K -250.21K -250.21K 1.25M -250.31K -250.31K -250.31K -250.35K n/a n/a n/a n/a 8.4K n/a 75K
Operating Income
-4.06M -2.16M -2.14M -2.83M -2.92M -3.37M -7.83M -3.64M -6.45M -3.04M -5.57M -9.81M -15.77M -2.96M -6.95M -2.62M -1.7M
Interest Income
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 146.06K n/a n/a 1.92K n/a n/a n/a
Pretax Income
-3.42M -3.01M -1.83M -3.04M -3M -3.76M -6.26M -3.11M -7.87M -2.94M -5.65M -9.8M -19.18M -2.84M -5.95M -2.71M -1.95M
Net Income
-3.06M -1.95M -1.83M -3.04M -3M -3.76M -6.26M -3.11M -9.26M -2.84M -5.73M -9.8M -3,408.6B -2.84M -5.95M -2.71M -1.95M
Selling & General & Admin
375.57K 4.21M 1.08M 2.18M 1.9M 2.1M 2.83M 3.22M 6.42M 3.22M 5.49M 9.75M 15.72M 3.04M 6.76M 2.58M 1.74M
Research & Development
86.66K 343.88K 811.78K 398.82K 777.07K 1.01M 4.98M 377.04K 25.74K 20.89K 20.89K n/a n/a n/a n/a n/a n/a
Other Expenses
3.57M n/a 250K n/a n/a n/a -38.6K n/a 35.00 318.7K n/a -5K n/a n/a n/a n/a n/a
Operating Expenses
4.03M 4.55M 2.14M 2.58M 2.67M 3.12M 7.81M 3.6M 6.45M 3.22M 5.51M 9.75M 15.72M 3.04M 6.76M 2.58M 1.74M
Interest Expense
-71.49K n/a 50.93K 66.06K 200.5K 13.83K 19.8K 42.64K 31.42K 42.34K 56.42K 63.83K 55.82K -77.33K 188.56K 43.1K 34.74K
Selling & Marketing Expenses
106.5K -1.63M n/a 5K 1.63M n/a 12.41K 300.00 n/a 1.42K 2.86K 4.05K n/a n/a n/a n/a 2.92K
Cost & Expenses
4.07M 5.48M 2.14M 2.83M 2.92M 3.37M 7.81M 3.6M 6.45M 3.22M 5.51M 9.75M 15.72M 3.04M 6.76M 2.58M 1.74M
Income Tax Expense
-363.21K -1.06M n/a n/a n/a -1.41M -18.8K 42.64K 1.39M -100.29K 80K 58.83K 3,408.6B n/a n/a n/a n/a
Shares Outstanding (Basic)
3.07M 1.92M 39.81M 37.57M 35.54M 35.33M 26.65M 21.81M 20.08M 14.3M 19.52M 20.44M 20.44M 9.38M 20.44M 20.44M 20.44M
Shares Outstanding (Diluted)
3.07M 1.92M 39.81M 37.57M 35.54M 35.33M 26.65M 21.81M 20.08M 14.3M 20.44M 20.44M 20.44M 9.38M 20.44M 20.44M 20.44M
EPS (Basic)
-1.11 4.09 -0.05 -0.08 -0.08 -0.11 -0.23 -0.14 -0.46 -0.2 -0.29 -0.48 -166.75K -0.3 -0.29 -0.13 -0.1
EPS (Diluted)
-1.11 4.09 -0.05 -0.08 -0.08 -0.11 -0.23 -0.14 -0.46 -0.2 -0.28 -0.48 -166.75K -0.3 -0.29 -0.13 -0.1
EBITDA
-4.06M -2.67M -1.5M -2.72M -2.55M -3.49M -6.08M -2.91M -7.68M -2.65M -5.34M -9.49M -15.46M -2.47M -6.95M -2.67M -1.91M
EBIT
n/a -2.93M -1.78M -2.97M -2.8M -4.01M -6.33M -3.16M -7.93M -2.9M -5.59M -9.74M -19.12M -2.92M -5.76M -2.67M -1.92M
Depreciation & Amortization
n/a -778.65K 278.23K 250.21K 250.21K 250.31K 250.31K 250.31K 250.31K 250.35K 250.35K 250.35K 250.35K 446.2K 366.00 367.00 481.00